The Global Health Body Sounds Warning Over Acute Shortage of Obesity Injections

Under a tenth of people who could benefit from GLP-1 drugs including Wegovy are able to get them, caution the World Health Organization as it publishes its inaugural advice on the therapies.

Considering over a billion people worldwide now obese, it is urging increased and just access to these injectable treatments.

Based on estimates, more than two billion could be living with obesity by 2030 if no action is taken.

"Our latest guidance recognises that excess weight is a long-term condition that can be managed with thorough and lifelong treatment," said its chief Tedros Adhanom Ghebreyesus.

High costs, limited production capacity, and logistical bottlenecks are significant hurdles to universal access to the injections that can assist patients in reducing considerable weight, says the organization.

Skinny Jab Supply Crisis

Despite the present most optimistic case, the production of these medications would only suffice for about 100 million people – under 10% of the global need, according to the health organization.

The advice calls on nations and manufacturers to widen access, by approaches including voluntary licensing.

Exclusive production rights on semaglutide – the main component of Novo Nordisk's Wegovy – is scheduled to end in several nations in 2026.

How Obesity Injections Function

GLP-1 drugs replicate a natural hormone to reduce digestion speed, suppress the appetite and boost satiety so users eat less.

Patients typically begin shedding pounds in the initial weeks of commencing the once-weekly jabs.

Evidence suggests patients may see weight return after a year of stopping the medication, when their typical hunger return.

To be overweight or obese elevates your chance for developing medical conditions, such as type 2 diabetes, cardiovascular issues, brain attack, and some malignancies.

Obesity concerns individuals in countries worldwide and was responsible for over three and a half million deaths worldwide in 2024, according to the health agency.